跳至主要内容
临床试验/CTRI/2024/08/072909
CTRI/2024/08/072909尚未招募3 期

Effectiveness, efficacy, and feasibility of a therapist-aided app for Exposure and Response Prevention: A Parallel-group, Pilot Randomised Control Trial

IHUB Anubhuti-IITD Foundation (IHUB)1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
The primary outcome measure would be considered as the change in client adherence to homework of ERP therapy as assessed by Patient EX/RP Adherence Scale (PEAS).

研究概览

简要总结

It is pilot, parallel-group randomised trial to assess the efficacy, feasibility and acceptability of adding a bilingual Exposure and Response Prevention App to usual standard of care, ie, Exposure and Response Prevention for patients diagnosed with obsessive compulsive disorder (OCD). The rationale for developing the app has been the difficulty patients face in completing homework sessions between sessions, which are essential to promote recovery and decrease symptom severity. The app aims to provide psychoeducative material on OCD and ERP; give personalised reminders to complete HW everyday and track the level of anxiety. 

Patients meeting the inclusion/exclusion criteria would be randomized into one of the two groups. The first group would be TAU/Standard care, wherein a trained clinical psychologist would take ERP sessions once in a week. The second group would get access to the bilingual, therapist- enhanced ERP app, along with weekly ERP sessions by the clinical psychologist. The clinical psychologist would be regularly supervised by SKG.In both the groups, ERP would follow a module-based approach to ensure consistency. To assess treatment fidelity, 20% of the sessions in both the groups would be recorded (while ensuring confidentiality) and reviewed by either SKG or KSD and rated on a Likert scale of 0 (not matching the module) to 10 (complete fit to the module). Both groups would go through baseline assessments that would include socio-demographic and clinical profile, CGI, and Y-BOCS. After every session, the therapist would fill the Patient EX/RP Adherence Scale (PEAS). Y-BOCS would be administered again at the end of the 4th session. The assessment at the end-of-intervention would be conducted by a Clinical Psychologist/Psychiatrist blinded to the randomization.

Participant dropouts will be managed by implementing a reminder system. In the event that a participant misses a session, a reminder will be issued via phone call. If a participant misses only one session, their latest recorded data will be carried forward, allowing them to remain enrolled in the study. However, if a participant misses two or more sessions, they will be classified as dropout from the study. This approach aims to maintain participant engagement and data continuity by accommodating occasional absences while ensuring that consistent participation is upheld for the integrity of the study results.

Adequate measures would be taken for data safety.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 1.Age between 18-40 years 2.Meeting diagnostic criteria for Obsessive Compulsive Disorder and per International Classification of Diseases-tenth edition (ICD-10) 3.Duration of illness≥ 2 years 4.Having access to smartphone 5.Able to read English and Hindi.

排除标准

  • OCD with predominantly obsessions (without compulsions) 2.Depressive disorder with scores on Beck Depressive Inventory (BDI-II)≥ 14 3.Current active suicidal ideations 4.Patients with comorbid or history of severe mental illness such as schizophrenia, Bipolar affective disorder, Intellectual disability or Autism spectrum disorders 5.Patients with organic brain disorder or other neurological conditions 6.Unwilling or unable to provide consent.

结局指标

主要结局

The primary outcome measure would be considered as the change in client adherence to homework of ERP therapy as assessed by Patient EX/RP Adherence Scale (PEAS).

时间窗: 1 week after the first session, week 2 (2nd session), week 3 (3rd session) and 4 weeks (4th session)

次要结局

  • The secondary outcome would be measured by the change in OCD symptoms as measured by decrease in Y- BOCS score(Baseline (Day 0) and Session 4 (Day 28))
  • The secondary outcome would be measured by the change in OCD symptoms as measured by decrease in Clinicial Global Impression (CGI) score(Baseline (Day 0) and Session 4 (Day 28))

研究者

发起方
IHUB Anubhuti-IITD Foundation (IHUB)
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Swati Kedia Gupta

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验